Harbor Investment Advisory’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Sell |
2,950
-805
| -21% | -$39.2K | 0.01% | 425 |
|
|
2025
Q1 | $128K | Sell |
3,755
-700
| -16% | -$23.8K | 0.01% | 426 |
|
|
2024
Q4 | $175K | Sell |
4,455
-1,350
| -23% | -$53.1K | 0.02% | 371 |
|
|
2024
Q3 | $273K | Sell |
5,805
-20
| -0.3% | -$940 | 0.03% | 303 |
|
|
2024
Q2 | $315K | Sell |
5,825
-345
| -6% | -$18.6K | 0.03% | 275 |
|
|
2024
Q1 | $421K | Hold |
6,170
| – | – | 0.04% | 247 |
|
|
2023
Q4 | $386K | Sell |
6,170
-450
| -7% | -$28.2K | 0.04% | 241 |
|
|
2023
Q3 | $300K | Sell |
6,620
-4
| -0.1% | -$182 | 0.04% | 259 |
|
|
2023
Q2 | $372K | Sell |
6,624
-550
| -8% | -$30.9K | 0.05% | 259 |
|
|
2023
Q1 | $324K | Sell |
7,174
-700
| -9% | -$31.7K | 0.05% | 276 |
|
|
2022
Q4 | $320K | Sell |
7,874
-3,250
| -29% | -$132K | 0.05% | 269 |
|
|
2022
Q3 | $727K | Sell |
11,124
-200
| -2% | -$13.1K | 0.12% | 153 |
|
|
2022
Q2 | $688K | Sell |
11,324
-50
| -0.4% | -$3.04K | 0.11% | 165 |
|
|
2022
Q1 | $714K | Sell |
11,374
-4,170
| -27% | -$262K | 0.09% | 178 |
|
|
2021
Q4 | $1.18M | Sell |
15,544
-530
| -3% | -$40.2K | 0.15% | 122 |
|
|
2021
Q3 | $1.8M | Sell |
16,074
-320
| -2% | -$35.8K | 0.24% | 79 |
|
|
2021
Q2 | $2.65M | Buy |
16,394
+350
| +2% | +$56.7K | 0.36% | 58 |
|
|
2021
Q1 | $1.96M | Buy |
16,044
+676
| +4% | +$82.4K | 0.29% | 71 |
|
|
2020
Q4 | $2.35M | Buy |
15,368
+3,120
| +25% | +$478K | 0.38% | 60 |
|
|
2020
Q3 | $1.02M | Sell |
12,248
-1,711
| -12% | -$143K | 0.2% | 99 |
|
|
2020
Q2 | $1.03M | Buy |
13,959
+3,656
| +35% | +$269K | 0.22% | 90 |
|
|
2020
Q1 | $437K | Buy |
10,303
+804
| +8% | +$34.1K | 0.12% | 142 |
|
|
2019
Q4 | $579K | Buy |
+9,499
| New | +$579K | 0.13% | 141 |
|